CAS RN: 35404-50-3
CYCLOCREATINE
Product Availability
Choose a grade to view its available package options.
3 package records 3 with current stock 1 grade group
Grade
98% (3)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20260129
1g
In stock
Shanghai Inquiry
Batchno.20250826
250mg
In stock
Shanghai Inquiry
Batchno.20251018
5g
In stock
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 35404-50-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Hong Kong
Inquiry
35404-50-3 / 2-(2-amino-4,5-dihydroimidazol-1-yl)acetic acid
Standard CAS: 35404-50-3
Multi CAS: Yes
Basic Information
copy
CAS
35404-50-3 copy
Multi CAS
Yes copy
Molecular Formula
C5H9N3O2 copy
Molecular Weight
143.140000 copy
Exact Mass
143.069477 copy
InChI
InChI=1S/C5H9N3O2/c6-5-7-1-2-8(5)3-4(9)10/h1-3H2,(H2,6,7)(H,9,10) copy
InChIKey
AMHZIUVRYRVYBA-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Fraction Csp3
0.6 copy
Rotatable bonds
2 copy
H-bond acceptors
4 copy
H-bond donors
2 copy
Molar refractivity
35.7 copy
TPSA
78.92 copy
LogP / Solubility
WLOGP
-1.3 copy
MLOGP
-1.15 copy
XLogP3
-1.6 copy
Consensus LogP
-1.35 copy
Log S (ESOL)
0.22 copy
Class (ESOL)
Highly soluble copy
Log S (Ali)
0.2 copy
Class (Ali)
Highly soluble copy
Log S (SILICOS-IT)
0.25 copy
Class (SILICOS-IT)
Highly soluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-4.52 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy